文献速递肺栓塞与肺血管病

静脉淤血超声评分在肺动脉高压患者中的多中心有创验证

Multicenter Invasive Validation of the Venous Excess Ultrasound Score in Patients Referred for Pulmonary Hypertension.
PubMed 文献 · Chest · 2026-08-29

VExUS评分与有创测量的右心房压力呈强分级关联,对RAP≥12 mmHg的判别AUC为0.97,优于孤立超声指标。

要点

  • VExUS评分与有创RAP呈强分级关联,评分0至3对应平均RAP从3.9升至15.8 mmHg。
  • VExUS对RAP≥12 mmHg的AUC为0.97(95%CI 0.94-0.99),判别力优秀。
  • VExUS诊断性能优于孤立超声指标,与超声RAP估测相当,各血流动力学表型一致。

核心结论

  • 在转诊肺动脉高压患者中,VExUS评分密切反映有创测量的右心房压力,提供稳健的床旁全身静脉淤血评估。

研究设计与样本

  • 多中心观察性研究,覆盖7个意大利参考中心,纳入转诊肺动脉高压且1小时内完成VExUS评估与右心导管检查的患者。
  • 共纳入145例毛细血管前肺动脉高压(多为PAH)、21例毛细血管后肺动脉高压和21例无肺动脉高压患者。
  • VExUS评分基于下腔静脉直径与塌陷性及肝、门、肾内静脉血流多普勒模式,按0至3分级计算。

主要发现

  • VExUS评分与RAP呈强分级关联:评分0、1、2、3对应的平均RAP分别为3.9、8.4、13.5、15.8 mmHg(P < .001)。
  • VExUS评分对RAP≥12 mmHg的ROC曲线下面积为0.97(95%CI 0.94-0.99)。
  • VExUS诊断性能高于孤立超声标志物,与超声RAP估测相当,且在各血流动力学表型中一致。

关键数值与推荐

  • VExUS评分0至3分级基于下腔静脉直径和塌陷性及肝、门、肾内静脉血流多普勒评估。
  • 以有创RAP≥12 mmHg为抬高阈值评估VExUS诊断性能。
  • 判别力AUC为0.97(95%CI 0.94-0.99)。

临床怎么用

  • VExUS可作为转诊肺动脉高压患者床旁评估全身静脉淤血的补充工具,辅助常规超声心动图评估。
  • VExUS评分升高提示RAP增高,可帮助识别需要进一步有创血流动力学评估的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Venous Excess Ultrasound (VExUS) score is used increasingly to assess systemic venous congestion, yet direct validation against invasively measured right atrial pressure (RAP) in pulmonary hypertension (PH) remains limited. RESEARCH QUESTION: How accurate is the VExUS score to predict RAP in patients with established or suspected PH? STUDY DESIGN AND METHODS: We conducted a multicenter observational study across 7 Italian reference centers including patients referred for PH and undergoing a VExUS assessment and right heart catheterization within 1 hour. A VExUS score was calculated with a 0 to 3 grading based on inferior vena cava (IVC) diameter and collapsibility and Doppler assessment of hepatic, portal, and intrarenal venous flow patterns. The diagnostic performance of VExUS for identifying elevated RAP thresholds was compared with echocardiographic estimates based on IVC diameter and inspiratory collapse and right atrium surface areas using a multivariable analysis followed by receiver operating characteristic (ROC) curve calculations. Subgroup analyses were performed across pulmonary hemodynamic phenotypes (normal hemodynamics vs precapillary PH vs postcapillary PH). RESULTS: The study included 145 patients with precapillary PH, most of whom demonstrated pulmonary arterial hypertension (PAH), 21 patients with postcapillary PH, and 21 patients with no PH. The VExUS score showed a strong graded association with RAP, with mean RAP increasing across VExUS scores (VExUS score 0, 3.9 mm Hg; VExUS score 1, 8.4 mm Hg; VExUS score 2, 13.5 mm Hg; and VExUS score 3, 15.8 mm Hg; P < .001). The VExUS score demonstrated excellent discrimination for elevated RAP of ≥ 12 mm Hg (area under the ROC curve, 0.97; 95% CI, 0.94-0.99), with higher diagnostic performance than isolated echocardiographic markers and performance comparable with that of echocardiographic RAP estimation. These findings were consistent across hemodynamic phenotypes. INTERPRETATION: In this multicenter cohort of patients referred for PH (most with PAH), the VExUS score closely reflected invasively measured RAP and provided a robust bedside assessment of systemic venous congestion that complements conventional echocardiographic evaluation.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. D'Alto M, Cangiano N, Orlando A, et al. Multicenter Invasive Validation of the Venous Excess Ultrasound Score in Patients Referred for Pulmonary Hypertension. Chest. 2026. PMID: 42668061. doi:10.1016/j.chest.2026.08.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。